Clinical trial
Prospective Randomized Placebo Controlled Blinded Study to Evaluate the Efficacy of Alfuzosin (Alpha Blocker) on the Success Rates Following SWL.
NCT00409227 is registered in ClinicalTrials.gov with Assaf-Harofeh Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Randomized Placebo Controlled Blinded Study to Evaluate the Efficacy of Alfuzosin (Alpha Blocker) on the Success Rates Following SWL.
- Lead sponsor
- Assaf-Harofeh Medical Center
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 31, 2006
- Completion date
- Not reported
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.